NRx Pharmaceuticals Inc (NASDAQ: NRXP) has signed an agreement with Cardinal Health Inc (NYSE: CAH) to provide third-party logistics and distribution of Zyesami upon the potential...
NRx Pharmaceuticals (NRXP) soars 15.8% premarket after signing an agreement with Cardinal Health (CAH) for third party logistics and distribution of Zyesami upon the potential...
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more...
Stocks that raised dividends last week.
The next major support level for Cardinal Health Inc stock will be around the $46.00 level. This key support area is where the stock broke out to the upside in early November 2020.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Buy | Neutral | Sell | Strong Sell |
| Technical Indicators | Strong Sell | Strong Buy | Strong Buy | Strong Sell | Strong Sell |
| Summary | Neutral | Strong Buy | Buy | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 1,464.00 | 1,478.00 | 1,459.00 | +4.00 | +0.27% | 170.25K | London | |||
| 142.00 | 158.00 | 142.00 | -11.50 | -7.33% | 13.55M | London | |||
| 80.60 | 82.00 | 71.60 | +7.00 | +9.51% | 963.82K | London | |||
| 283.40 | 285.30 | 280.70 | +2.80 | +1.00% | 8.59M | London | |||
| 119.00 | 119.00 | 119.00 | -6.50 | -5.16% | 1.25M | London | |||
| 158.65 | 160.95 | 157.80 | -1.65 | -1.03% | 19.26M | London | |||
| 268.50 | 272.10 | 268.50 | -0.30 | -0.11% | 2.13M | London | |||
| 3,338.00 | 3,386.00 | 3,310.00 | -7.0 | -0.21% | 286.95K | London | |||
| 1,645.00 | 1,670.50 | 1,644.00 | -7.00 | -0.42% | 2.21M | London | |||
| 329.30 | 332.85 | 324.20 | +5.10 | +1.57% | 38.78M | London | |||
| 23.60 | 24.40 | 23.60 | -0.30 | -1.26% | 15.00M | London | |||
| 45.06 | 45.13 | 44.09 | +1.08 | +2.46% | 170.00M | London | |||
| 188.35 | 189.95 | 187.85 | +0.10 | +0.05% | 3.57M | London | |||
| 31.75 | 31.75 | 31.75 | 0.00 | 0.00% | 352.99K | London | |||
| 125.40 | 125.40 | 125.00 | +0.80 | +0.64% | 443.03K | London |
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.